162 related articles for article (PubMed ID: 24509250)
1. Effect of antisera from Clostridium difficile-infected mice on toxin-A-induced colonic epithelial cell death signaling.
Kim DH; Lee IH; Nam ST; Nam HJ; Kang JK; Seok H; Hwang JS; Kim H
J Microbiol Biotechnol; 2014 May; 24(5):696-703. PubMed ID: 24509250
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
3. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
4. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
[TBL] [Abstract][Full Text] [Related]
5. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.
Giannasca PJ; Zhang ZX; Lei WD; Boden JA; Giel MA; Monath TP; Thomas WD
Infect Immun; 1999 Feb; 67(2):527-38. PubMed ID: 9916055
[TBL] [Abstract][Full Text] [Related]
6. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment.
Mahida YR; Makh S; Hyde S; Gray T; Borriello SP
Gut; 1996 Mar; 38(3):337-47. PubMed ID: 8675084
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.
Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY
BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596
[TBL] [Abstract][Full Text] [Related]
8. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile.
Johnson S; Gerding DN; Janoff EN
J Infect Dis; 1992 Dec; 166(6):1287-94. PubMed ID: 1431247
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
[TBL] [Abstract][Full Text] [Related]
10. Effects of Clostridium difficile toxins on epithelial cell barrier.
Pothoulakis C
Ann N Y Acad Sci; 2000; 915():347-56. PubMed ID: 11193598
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis.
Saavedra PHV; Huang L; Ghazavi F; Kourula S; Vanden Berghe T; Takahashi N; Vandenabeele P; Lamkanfi M
Nat Commun; 2018 Nov; 9(1):4846. PubMed ID: 30451870
[TBL] [Abstract][Full Text] [Related]
12. Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model.
Cohen OR; Steele JA; Zhang Q; Schmidt DJ; Wang Y; Hamel PE; Beamer G; Xu B; Tzipori S
PLoS One; 2014; 9(10):e111075. PubMed ID: 25347821
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.
Andersen KK; Strokappe NM; Hultberg A; Truusalu K; Smidt I; Mikelsaar RH; Mikelsaar M; Verrips T; Hammarström L; Marcotte H
Infect Immun; 2016 Feb; 84(2):395-406. PubMed ID: 26573738
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.
Yang Z; Ramsey J; Hamza T; Zhang Y; Li S; Yfantis HG; Lee D; Hernandez LD; Seghezzi W; Furneisen JM; Davis NM; Therien AG; Feng H
Infect Immun; 2015 Feb; 83(2):822-31. PubMed ID: 25486992
[TBL] [Abstract][Full Text] [Related]
15. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits.
Ketley JM; Mitchell TJ; Candy DC; Burdon DW; Stephen J
J Med Microbiol; 1987 Aug; 24(1):41-52. PubMed ID: 3612743
[TBL] [Abstract][Full Text] [Related]
16. NQO1-Knockout Mice Are Highly Sensitive to Clostridium Difficile Toxin A-Induced Enteritis.
Nam ST; Hwang JH; Kim DH; Lu LF; Hong J; Zhang P; Yoon IN; Hwang JS; Chung HK; Shong M; Lee CH; Kim H
J Microbiol Biotechnol; 2016 Aug; 26(8):1446-51. PubMed ID: 27116994
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Clostridium difficile-associated diarrhoea.
Pothoulakis C
Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1041-7. PubMed ID: 8944363
[TBL] [Abstract][Full Text] [Related]
18. Immune response to Clostridium difficile infection.
Kelly CP
Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1048-53. PubMed ID: 8944364
[TBL] [Abstract][Full Text] [Related]
19. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
20. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]